期刊文献+

Effect and mechanism of Polygonatum sibiricum polysaccharide on osteogenic differentiation of bone mesenchymal stem cells(BMSCs)

Effect and mechanism of Polygonatum sibiricum polysaccharide on osteogenic differentiation of bone mesenchymal stem cells(BMSCs)
下载PDF
导出
摘要 Objective:To investigate the effects and mechanisms of Polygonatum sibiricum polysaccharide(PSP)on osteogenic differentiation of bone marrow mesenchymal stem cells(BMSCs).Methods:The mouse BMSCs were cultured and induced in osteoblast medium(OBM)containing finalconcentrations(0 mg/L,12.5 mg/L,25 mg/L,and 50 mg/L)of PSP.The proliferation and cytotoxicity of BMSCs were detected by MTT assay.Alkaline phosphatase(ALP)and Alizarin red S staining were performed after 7 days' ossification-inducing culture.The mRNA expressions of ALP,Runx2 and osteocalcin(OCN)were determined by fluorescence quantitative PCR(qPCR).The mRNA and protein expressions of Tafazzin(TAZ)(a key effector of Hippo pathway)were measured by qPCR and western blotting,respectively.Results:PSP was non-cytotoxicwithin the dose range of 12.5-50 mg/L and had no impact on the proliferation of BMSCs.The activity of ALP,the intensity of ALP staining,and the formation of mineralized nodules were increased by PSP treatment(25 and50 mg/L)(P<0.01).Moreover,administration of 25 mg/L PSP significantly enhanced the mRNA levels of osteoblastic differentiation makers ALP,Runx2 and OCN as well as the mRNA and protein expressions of TAZ(P<0.01).Conclusion:PSP could promote osteogenic differentiation of BMSCs,and the mechanisms might be related to the activation of TAZ in the Hippo signaling pathway. Objective:To investigate the effects and mechanisms of Polygonatum sibiricum polysaccharide(PSP)on osteogenic differentiation of bone marrow mesenchymal stem cells(BMSCs).Methods:The mouse BMSCs were cultured and induced in osteoblast medium(OBM)containing finalconcentrations(0 mg/L,12.5 mg/L,25 mg/L,and 50 mg/L)of PSP.The proliferation and cytotoxicity of BMSCs were detected by MTT assay.Alkaline phosphatase(ALP)and Alizarin red S staining were performed after 7 days' ossification-inducing culture.The mRNA expressions of ALP,Runx2 and osteocalcin(OCN)were determined by fluorescence quantitative PCR(qPCR).The mRNA and protein expressions of Tafazzin(TAZ)(a key effector of Hippo pathway)were measured by qPCR and western blotting,respectively.Results:PSP was non-cytotoxicwithin the dose range of 12.5-50 mg/L and had no impact on the proliferation of BMSCs.The activity of ALP,the intensity of ALP staining,and the formation of mineralized nodules were increased by PSP treatment(25 and50 mg/L)(P〈0.01).Moreover,administration of 25 mg/L PSP significantly enhanced the mRNA levels of osteoblastic differentiation makers ALP,Runx2 and OCN as well as the mRNA and protein expressions of TAZ(P〈0.01).Conclusion:PSP could promote osteogenic differentiation of BMSCs,and the mechanisms might be related to the activation of TAZ in the Hippo signaling pathway.
出处 《广西医科大学学报》 CAS 2018年第5期581-586,共6页 Journal of Guangxi Medical University
基金 supported by grants from National Natural Science Foundation of China(No.81360279) Guangxi Natural Science Foundation(No.2015GXNSFAA139150)
关键词 化合物 聚合物 化学分析 Polygonatum sibiricum polysaccharide BMSCs osteogenic differentiation ALP Hippo
  • 相关文献

参考文献3

二级参考文献57

  • 1Estberg L, Stover SM, Gardner IA, Johnson B J, Case JT, Ardans A, Read DH, Anderson ML, 13arr BC, Daft BM, Kinde H, Moore J, Stoltz J, Woods LW: Fatal musculoskeletal injuries incurred during racing and training in thoroughbreds. J Am Vet Med Assoc 1996, 208:92-96.
  • 2Lewis JM: New ~echnology could help reduce bone froctures in horses. DVMJdO.com, July f, 2008.
  • 3Beyer A: Life, savings contribute to difficult calculation, The Woshington Post 2006. Sunday, May 28.
  • 4Galuppo L: Equine Fractures: Emergency First Aid and Stabilization Techniques. CEH The Horse Report, 22:1-4.
  • 5Blanchette A: A second chance for Abby. S~arTribune 2008:.
  • 6Perren SM: Fracture healing. The evolution of our understanding. Acta Chit Orthop Traumatol Cech 2008, 75:241-246.
  • 7Schindeier A, McDonald MM, Bokko P, Little DG: Bone remodeling during fracture repair: The cellular picture. Semin Cell Dev Biol 2008, 19:459-466.
  • 8Milner PI, Clegg PD, S~ewart MC: Stem cell-based therapies for bone repair. Vet C/in North Am Equine Proct 2011, 27:299-314.
  • 9Kraus KH, Kirker-Head C: Mesenchymal stem cells and bone regeneration. Vet 5urg 2006, 35:232-242.
  • 10Koch TG, Berg LC, Betts DH: Concepts for the clinical use of stem cells in equine medicine. Con Ve~ J 2008, 49:1009-1017.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部